The Chemours Company $CC Stock Holdings Decreased by Peregrine Capital Management LLC

Peregrine Capital Management LLC lowered its position in shares of The Chemours Company (NYSE:CC) by 8.8% during the first quarter, Holdings Channel reports. The fund owned 334,117 shares of the specialty chemicals company’s stock after selling 32,244 shares during the quarter. Peregrine Capital Management LLC’s holdings in Chemours were worth $7,361,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. WINTON GROUP Ltd lifted its holdings in shares of Chemours by 103.5% in the third quarter. WINTON GROUP Ltd now owns 114,100 shares of the specialty chemicals company’s stock valued at $1,807,000 after purchasing an additional 58,039 shares in the last quarter. Hudson Bay Capital Management LP purchased a new position in shares of Chemours during the third quarter valued at $1,925,000. SG Americas Securities LLC grew its holdings in shares of Chemours by 478.4% during the fourth quarter. SG Americas Securities LLC now owns 236,236 shares of the specialty chemicals company’s stock valued at $2,785,000 after buying an additional 195,393 shares in the last quarter. Wolf Hill Capital Management LP acquired a new position in Chemours during the third quarter valued at $17,025,000. Finally, American Century Companies Inc. raised its position in Chemours by 26.0% during the third quarter. American Century Companies Inc. now owns 2,378,591 shares of the specialty chemicals company’s stock valued at $37,677,000 after buying an additional 490,988 shares during the period. Hedge funds and other institutional investors own 76.26% of the company’s stock.

Analyst Upgrades and Downgrades

CC has been the subject of several research reports. Morgan Stanley raised their price target on shares of Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. JPMorgan Chase & Co. increased their price target on shares of Chemours from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, May 21st. Alembic Global Advisors restated an “overweight” rating and set a $30.00 price target on shares of Chemours in a report on Wednesday, May 13th. Mizuho reduced their price objective on shares of Chemours from $30.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Truist Financial upped their price objective on shares of Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. Six research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $24.10.

Chemours Trading Down 1.9%

Shares of CC stock opened at $20.12 on Thursday. The Chemours Company has a 12 month low of $10.44 and a 12 month high of $28.67. The company has a market cap of $3.03 billion, a PE ratio of -7.62 and a beta of 1.41. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98. The business’s 50 day moving average is $22.70 and its two-hundred day moving average is $19.20.

Chemours (NYSE:CC) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. The business had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. Chemours’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.13 earnings per share. Equities analysts predict that The Chemours Company will post 1.07 EPS for the current year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Sunday, May 17th were given a dividend of $0.0875 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a yield of 1.7%. Chemours’s payout ratio is currently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.